top of page

All Posts


Predicting Response and Personalizing Treatment Decisions in Mental Health: New Opportunities with AI and Real-World Data
Webinar Fiercepharma OM1 Mental health conditions can take a significant toll on an individual, physically, socially, and financially....
kenashman
Jun 201 min read
Â
Â


First major overhaul of medical device regulation comes into force across Great Britain
MHRA published 16 June 2025 New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical...
kenashman
Jun 171 min read
Â
Â


Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
Healthcare IT News 16 June 2025 Datavant , a leading health data platform company, today announced that it has signed an agreement to...
kenashman
Jun 171 min read
Â
Â


MaaT Pharma Presents Updated Positive Data in Early Access Program for Xervyteg® at the EHA Congress
MaaT Press release 13 June 2025 MaaT will present updated data for Xervyteg® (MaaT013) in treating acute Graft-versus-Host Disease...
kenashman
Jun 171 min read
Â
Â


How AI is revolutionizing health care through real-world data
Published 1 June 2025 Turning real world data into insights A lot has been said and written about the potential of artificial...
kenashman
Jun 121 min read
Â
Â


The Future of Pharma: How Real-World Evidence & AI Are Shaping Market Access in 2025
Published 22 April 2025 WLCUS In 2025, AI-driven healthcare  and real-world data  (RWD) are transforming how treatments are evaluated,...
kenashman
Jun 121 min read
Â
Â


Using LLMs to Simplify Real-World Evidence Research - In Person at ISPOR 2025
Event 13 May 2025 ISPOR Discover how artificial intelligence (AI) is transforming real-world evidence (RWE) research, enabling more...
kenashman
Jun 121 min read
Â
Â


External Control Arms Based on Real World Data: MHRA Consultation Opens
Published 21 May 2025 by JASPREET TAKHAR , JULIA GILLERT  AND ELINA ANGELOUDI The UK’s MHRA unveiled a major shift: a consultation on...
kenashman
Jun 122 min read
Â
Â


Expanding the Use of Real-World Evidence Can Make FDA Regulatory Decisions Faster, Cheaper, and Just as Safe
Published 27 March 2025 Manhattan Institute New information technology gives the U.S. an opportunity to accelerate the development,...
kenashman
Jun 121 min read
Â
Â


Real World Evidence (RWE) Oncology Market to Reach $3.51 Billion by 2035
Published 27 May 2025 PR Newswire Market Growth Driven by Increasing Demand for Real-World Evidence in Drug Development, Rising Focus on...
kenashman
Jun 121 min read
Â
Â


A comprehensive overview of real-world evidence in medical device approvals in the United States
Published 28 May 2025 PubMed Despite the U.S. Food and Drug Administration (FDA)'s recognition of the value of real-world evidence (RWE)...
kenashman
Jun 121 min read
Â
Â


Target trial emulation and other frameworks
Event 26 June 2025 London School of Hygiene & Tropical Medicine Join the Centre for Data and Statistical Science for Health for a...
kenashman
Jun 121 min read
Â
Â


FDA updates its comprehensive guidance on Real-World Evidence
Published 9 June 2025 FDA website The FDA updated its comprehensive guidance on real-world evidence, emphasizing commitment to realizing...
kenashman
Jun 122 min read
Â
Â


MHRA draft guideline on the use of external control arms based on real-world data to support regulatory decisions
Published 20 May 2025 Summary MHRA invites feedback on the clarity and wording of their new draft guideline on the use of external...
kenashman
Jun 122 min read
Â
Â


Negative Control Outcomes in Observational Studies of Effectiveness : ISPOR Webinar
Wed 18 June 2025 Real-world data are increasingly being used to supplement traditional randomized clinical trials in the evaluation of...
kenashman
Jun 121 min read
Â
Â


How AI, Data Analytics, and Outcomes-Based Contracts Are Shaping Health Care
AJMC 9 April 2025 by Pearl Steinzor and Laura Bobolts Commentary and video Laura Bobolts, PharmD, BCOP, senior vice president of clinical...
kenashman
May 131 min read
Â
Â


DLBCL Outcomes Vary Sharply for Patients 80 Years and Older
AJMC 16 April 2025 by Maggie Shaw Patients who are 80 years and older who have diffuse large B-cell lymphoma (DLBCL), the most common...
kenashman
May 131 min read
Â
Â


Swiss study adds to concern about GLP-1 agonists link to vision issues
Juta Medical Brief 16 April 2025 Using real-world data from more than 300 000 cases, scientists have uncovered a significant link between...
kenashman
May 131 min read
Â
Â


A scoping review of OMOP CDM adoption for cancer research using real world data
Nature 7 April 2025 The Observational Medical Outcomes Partnership (OMOP) common data model (CDM) supports large-scale research by...
kenashman
May 131 min read
Â
Â


Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer
Targeted Oncology 9 April 2025 by Seth Wander Commentary | Video At the American Society of Clinical Oncology Annual Meeting (ASCO) and...
kenashman
May 131 min read
Â
Â
bottom of page